Characterization of dominant-negative forms of anthrax protective antigen

Molecular Medicine

Volumn 9, Issue 1-2, 2003, Pages 46-51

  Yan, Ming ^a   Collier, R John ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITOXIN; BACTERIAL ANTIGEN; MUTANT PROTEIN; UREA;

ANIMAL CELL; ANTHRAX; ARTICLE; ATTENUATION; CELL ASSAY; CHANNEL GATING; CHO CELL; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IMMUNOASSAY; LIGAND BINDING; MOLECULAR CLONING; NONHUMAN; PH; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; WILD TYPE;

EID: 0037868151     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402106     Document Type: Article

References (16)

1. Leppla SH. (1991) The anthrax toxin complex. In: Alouf J (ed.) Sourcebook of Bacterial Protein Toxins. Academic Press, New York, pp. 277-302.
2. Mourez M et al. (2002) 2001: a year of major advances in anthrax toxin research. Trends Microbiol. 10:287-93.
3. Klimpel KR, Molloy SS, Thomas G, Leppla SH. (1992) Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. U.S.A. 89:10277-81.
4. Gordon VM, Klimpel KR, Arora N, Henderson MA, Leppla SH. (1995) Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect. Immun. 63:82-7.
5. Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC. (1997) Crystal structure of the anthrax toxin protective antigen. Nature 385:833-8.
6. Milne JC, Furlong D, Hanna PC, Wall JS, Collier RJ. (1994) Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:20607-12.
7. Friedlander AM. (1986) Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261:7123-6.
8. Blaustein RO, Koehler TM, Collier RJ, Finkelstein A. (1989) Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers. Proc. Natl. Acad. Sci. U.S.A. 86:2209-13.
9. Leppla SH. (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. U.S.A. 79:3162-66.
10. Duesbery NS et al. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factar. Science 280:734-7.
11. Pellizzari R, Guidi-Rontani C, Vitale G, Mock M, Montecucco C. (1999) Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ-induced release of NO and TNFα. FEBS Lett. 462:199-204.
12. Benson EL, Huynh PD, Finkelstein A, Collier RJ. (1998) Identification af residues lining the anthrax protective antigen channel. Biochemistry 37:3941-8.
13. Sellman BR, Nassi S, Collier RJ. (2001) Point mutations in anthrax protective antigen that block translocation. J. Biol. Chem. 276:8371-6.
14. Miller CJ, Elliott JL, Collier RJ. (1999) Anthrax protective antigen: prepore-to-pore conversion. Biochemistry 38:10432-41.
15. Sellman BR, Mourez M, Collier RJ. (2001) Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Science 292:695-7.
16. Singh Y, Khanna H, Chopra AP, Mehra V. (2001) A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo. J. Biol. Chem. 276:22090-4.